Disorders of Dental Hard Tissues Induced by Radioiodine-131 (I-131) Therapy Used in Differentiated Thyroid Cancer: An In Vitro Study.

dental hard tissue differentiated thyroid cancer oral disease radioiodine therapy

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
05 Nov 2020
Historique:
received: 14 10 2020
accepted: 03 11 2020
entrez: 10 11 2020
pubmed: 11 11 2020
medline: 11 11 2020
Statut: epublish

Résumé

This study aimed to evaluate, in vitro, the effects of I-131 on enamel and dentin in healthy human incisive permanent maxillary teeth. Our in vitro model analogue with the in vivo conditions of differentiated thyroid carcinoma patients treated with I-131, consisted in a solution of I-131 dissolved in artificial saliva. A total of 48 teeth were divided into eight groups (n = 6): control, irradiation groups at 3, 6, 12, 24, 36, 48, and 192 h, respectively. At the end of radiation exposure, radioiodine activity of specimens was assessed. Fine microstructure, nanostructure, surface roughness, and hidroxyapatite (HAP) crystallite diameter were investigated by atomic force microscopy (AFM) to both enamel and dentin structures. There is a constant increase of radioactivity in dental structures at 3, 6, 12, 24 h, due to progressive retention and I-131 migration, with a maximum at 36 h. Enamel showed notable alterations, which was correlated with the increase of the treatment time. A relevant visible distance between the HAP prisms was observed after 24 h. The surface suffered a loss in its compact structure. I-131 acts in the same way on HAP crystallites in dentin as in those in enamel. It was noticed that their morpho-dimensional changes occurred only after 12 h of treatment. Radioiodine-131 determines degradation of enamel and dentin by starting from the alteration of the crystalline network of HAP prisms, transforming them from compact materials into an agglomeration of rocky submicron structures.

Identifiants

pubmed: 33167338
pii: biomedicines8110475
doi: 10.3390/biomedicines8110475
pmc: PMC7694335
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : European Social Found, Human Capital Operational Programme 2014-2020
ID : POCU/380/6/13/125171

Références

Radiat Oncol. 2014 Jan 22;9:30
pubmed: 24450404
Crit Rev Oral Biol Med. 2003;14(3):199-212
pubmed: 12799323
Ear Nose Throat J. 2000 Jun;79(6):460-8
pubmed: 10893838
N Engl J Med. 1983 Oct 20;309(16):937-41
pubmed: 6621620
Support Care Cancer. 2010 Jan;18(1):83-7
pubmed: 19373495
ACS Appl Mater Interfaces. 2015 Sep 2;7(34):18937-43
pubmed: 26266571
Curr Radiopharm. 2013 Dec;6(4):249-52
pubmed: 24410626
J Oral Biosci. 2019 Dec;61(4):207-214
pubmed: 31669717
Clin Oral Investig. 2018 May;22(4):1795-1803
pubmed: 29151196
Thyroid. 2003 Mar;13(3):265-71
pubmed: 12729475
Radiat Oncol. 2019 Jan 11;14(1):5
pubmed: 30635005
J Dent. 2014 Aug;42(8):986-92
pubmed: 24887361
Thyroid. 2013 May;23(5):609-16
pubmed: 23153322
Nucl Med Mol Imaging. 2014 Sep;48(3):203-11
pubmed: 25177377
Lancet Oncol. 2006 Apr;7(4):326-35
pubmed: 16574548
J Appl Clin Med Phys. 2018 Jul;19(4):134-140
pubmed: 29858536
Am J Roentgenol Radium Ther Nucl Med. 1962 Jan;87:171-82
pubmed: 13867399

Auteurs

Alexandru Mester (A)

Department of Oral Health, University of Medicine and Pharmacy "Iuliu Hatieganu", 400012 Cluj-Napoca, Romania.

Andra Piciu (A)

Department of Medical Oncology, University of Medicine and Pharmacy "Iuliu Hatieganu", 400012 Cluj-Napoca, Romania.

Doina Piciu (D)

Department of Endocrine Tumors and Nuclear Medicine, Oncology Institute "Ion Chiricuta", University of Medicine and Pharmacy "Iuliu Hatieganu, 400012 Cluj-Napoca, Romania.

Ioan Petean (I)

Faculty of Chemistry and Chemical Engineering, University Babes-Bolyai, 400294 Cluj-Napoca, Romania.

Patricia Ondine Lucaciu (PO)

Department of Oral Health, University of Medicine and Pharmacy "Iuliu Hatieganu", 400012 Cluj-Napoca, Romania.

Dragos Apostu (D)

Department of Orthopedics, University of Medicine and Pharmacy "Iuliu Hatieganu", 400012 Cluj-Napoca, Romania.

Cristina Moisescu-Goia (C)

Department of Endocrine Tumors and Nuclear Medicine, Oncology Institute "Ion Chiricuta", University of Medicine and Pharmacy "Iuliu Hatieganu, 400012 Cluj-Napoca, Romania.

Andrada Voina-Tonea (A)

Department of Dental Materials, University of Medicine and Pharmacy "Iuliu Hatieganu", 400012 Cluj-Napoca, Romania.

Marioara Moldovan (M)

Department of Polymer Composites, Institute of Chemistry "Raluca Ripan", University Babes-Bolyai, 400294 Cluj-Napoca, Romania.

Classifications MeSH